Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
probiotic prawn oral immunotherapy
- Development stage
- Unknown
- Lead developer
- Murdoch Children's Research Institute
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Probiotic prawn oral immunotherapy (ProPIT) is an investigational allergen-specific immunotherapy developed by the Murdoch Children's Research Institute for the treatment of IgE-mediated prawn allergy. The therapy utilizes the Probiotic and Food Oral Immunotherapy (PPOIT) platform, which combines the administration of prawn allergen proteins (primarily tropomyosin) with a probiotic (typically *Lactobacillus rhamnosus* CGMCC 1.3724) to modulate the immune system. The goal is to induce clinical desensitization or sustained unresponsiveness by shifting the immune response from a Th2-mediated allergic profile to a more tolerant state. It is currently being evaluated in the Phase 2b PIPA trial.
- Other names
- prawn oral immunotherapyprawn OITprobiotic prawn OIT
02
Targets
MHC II (Major histocompatibility complex class II receptor)sIgE-tropomyosin (Immunoglobulin E specific for cross-reactive invertebrate tropomyosins)Prawn tropomyosin-specific B-cell receptorTCR (T cell antigen receptor complex)IgE (Immunoglobulin E)TPM3 (Tropomyosin alpha-3 chain)
Beyond the preview
Go deeper on probiotic prawn oral immunotherapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on probiotic prawn oral immunotherapy.